What if the biggest driver of the antidepressant “effect” isn’t the drug, but your expectation? Learn why the placebo effect ...
For decades, scientists have investigated the neurokinin-1 receptor (NK1R) as a potential target for treating major ...
For decades, scientists have investigated the neurokinin-1 receptor (NK1R) as a potential target for treating major ...
If you’re interested in seeking ketamine treatment for depression, you probably have a few questions about how it all works.
In a major shift for how mental health conditions might be treated, the US Food and Drug Administration (FDA) has approved ...
Researchers compared a traditional Chinese medicine, Yueju Pill, with a standard antidepressant and found both reduced ...
More than 20% of all patients treated with the implant had essentially no symptoms of depression after two years, researchers ...
Investor's Business Daily on MSN
Psychedelics-tied GH skyrockets on FDA go-ahead for depression drug
Biotech stock GH Research catapulted Monday after the FDA gave it the go-ahead to resume testing its depression drug.
Kennedy’s antidepressant rhetoric is not only based on bad science, it fuels distrust in mental health treatments” in the ...
Her doctor prescribed an antidepressant, even though the then-36-year-old insisted she wasn’t depressed. She even went to ...
Researchers report that redesigning neurokinin-1 receptor (NK1R) antagonists can restore antidepressant-like effects in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback